Astellas Pharma Inc. and Propella Therapeutics, Inc. have entered into a merger agreement, marking a significant development in the field of digital wealth management. Through its U.S. subsidiary...
Posted by cathyy on September 05 2023 at 03:37 AM
public
Why need viral vector characterization?
Cell and gene therapies for various rare diseases are currently undergoing clinical trials worldwide. The rapid development in this field has led to an in...
According to research report the report Viral Vector Manufacturing Market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2% during the forecast perio...
Viral Vector Marketwas worth USD 0.60 billion in 2022 and is estimated to grow at a CAGR of 19.7% in the forecasted period. The forecasted revenue hints at a growth of around 2.13 billion USD by ...
